RecruitingNCT05985850
Cannabis oil added to methadone treatment for opioid use disorder
About this title
Read the official source — NCT05985850Medication studyAges 25+CanadaAddiction
Understand this study
Who could participate?
Listed age limits: from 25 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 23, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 24
- Sponsor
- BC Centre on Substance Use
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- Over 25 Years
- Official registry ID
- NCT05985850
- Official title
Show the full official title
Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy for Individuals Living With Opioid Use Disorder: A Phase II, Placebo-controlled, Blinded, Pilot Study to Assess Safety and Feasibility (THC-MMT)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is BC Centre on Substance Use.
Does this study involve medication?
Yes. The study involves medication, including Aurora 1:1 Drops (Indica) and Placebo.
Who can participate?
Listed age limits: from 25 years.
Is this study still recruiting?
The registry lists this study as recruiting.
